Michael Thomas Heffernan

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Wayne, PA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Lee Giguere, as attorney-in-fact for the Reporting Person
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Michael Thomas Heffernan

Form 4 holding Director

Biohaven Ltd.

Security class
Stock Options (Right to buy)
Shares / value
68,693
Estimated value
Report date
28 Apr 2026
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding Director

Trevi Therapeutics, Inc.

Security class
Nonstatutory Stock Option (right to buy)
Shares / value
35,000
Estimated value
Report date
03 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

SYNLOGIC, INC.

Security class
Stock Option (right to buy)
Shares / value
30,000
Estimated value
Report date
22 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Akebia Therapeutics, Inc.

Security class
Stock Option (Right to buy)
Shares / value
20,100
Estimated value
Report date
02 Jun 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Michael Thomas Heffernan

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .